Masimo upgraded by Raymond James with a new price target
$MASI
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Raymond James upgraded Masimo from Mkt Perform to Outperform and set a new price target of $170.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/27/2024 | $170.00 → $194.00 | Outperform | Raymond James |
| 11/6/2024 | $170.00 | Mkt Perform → Outperform | Raymond James |
| 6/3/2024 | $126.00 → $160.00 | Neutral → Overweight | Piper Sandler |
| 4/15/2024 | $148.00 → $170.00 | Hold → Buy | Stifel |
| 3/25/2024 | $117.00 → $160.00 | Equal Weight → Overweight | Wells Fargo |
| 1/30/2024 | $107.00 → $121.00 | Buy → Hold | Jefferies |
| 1/3/2024 | Buy → Hold | Needham | |
| 11/8/2023 | Outperform → Mkt Perform | Raymond James |